Research Archive — Page 101 of 137
-
September 4, 2019
Novel treatment for Prader-Willi syndrome being tested at VUMC
A novel treatment for Prader-Willi syndrome, one of the most common genetic causes of obesity, may improve the insatiable hunger that patients with the disorder experience. -
September 4, 2019
Partnership to help bring Zika virus therapy to clinic
Researchers at Vanderbilt University Medical Center are partnering with the Dutch biopharmaceutical firm Batavia Biosciences and Nashville-based IDBiologics to bring to the clinic a highly potent Zika virus neutralizing antibody they isolated three years ago. -
September 4, 2019
Vanderbilt Prize winner Seidman to speak Sept. 12
Christine Seidman, MD, recipient of the 2019 Vanderbilt Prize in Biomedical Science, will deliver her Vanderbilt Prize lecture at 4 p.m. Thursday, Sept. 12, in 208 Light Hall. -
August 27, 2019
A “rheostat” for cancer signals
Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells. -
August 26, 2019
Colorectal cancer researchers receive SPORE funding
Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI). -
August 26, 2019
Cancer susceptibility genes
Gene variants associated with cancer risk appear to contribute to carcinogenesis by regulating target genes that in turn promote the generation of mutations. -
August 22, 2019
How nerves may lose their insulation
Vanderbilt’s Bruce Carter and colleagues have discovered how genetic changes in the protein PMP22 may contribute to a disease of peripheral nerves.